By Dan Bobkoff, June 15, 2016
“There’s a new way of doing business for much of Big Pharma.
Instead of relying on their own expensive laboratories, they also buy drugs or their makers and focus on getting treatments through the Food and Drug Administration and onto your TV screens. Then, raise prices every year. Move overseas for tax advantages. And reward shareholders by buying back billions' worth of shares.
It wasn’t always like that.”
http://www.marketplace.org/2016/06/08/world/profit-pharma
Dan Bobkoff, June 15, 2016
“Our series, “The Price of Profits,” is looking at how the idea of maximizing shareholder value has changed American business and the nation, starting with where the idea came from. One starting point is the nation’s business schools. But what those schools teach is changing.”
http://www.marketplace.org/2016/06/08/world/profit-biz-school
By David Brancaccio, June 15, 2016
“In our series "The Price of Profits," we're exploring corporations. What are they for? Who are they for? And how that impacts the economy and you. Lord John Browne is the former CEO of BP and the co-author of "Connect: How Companies Succeed by Engaging Radically With Society." He spoke with Marketplace Morning Report host David Brancaccio about why incorporating society's needs in long-term thinking is the best strategy.”
http://www.marketplace.org/2016/06/09/economy/price-profits/former-bp-ceo-emphasizes-long-term
By Sabri Ben-Achour, June 15, 2016
http://www.marketplace.org/2016/06/08/world/profit-buybacks
By , June 16, 2016
“The past decade has seen an explosion in one particular type of investor: the activist shareholder. These are powerful hedge fund managers who make a lot of noise in corporate boardrooms. To some, they're the squeaky wheels of Wall Street.”
http://www.marketplace.org/2016/06/08/world/profit-markets